Business · 03/05/2001Updated: 10/17/2026 · 1 min read
Elanco Animal Health, A Div. of Eli Lilly & Co. et al.; Withdrawal of Approval of NADAs
Summary
The Food and Drug Administration (FDA) is withdrawing approval of 13 new animal drug applications (NADAs) at the request of the sponsor, and amending the animal drug regulations to remove the portions reflecting these approvals.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →